Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04892017 |
Title | A Phase 1/2 Study of DCC-3116 in Patients With RAS/MAPK Pathway Mutant Solid Tumors |
Recruitment | Recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | Yes |
Sponsors | Deciphera Pharmaceuticals LLC |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Massachusetts General Hospital | RECRUITING | Boston | Massachusetts | 02114 | United States | Details |
Rutgers Cancer Institute | RECRUITING | New Brunswick | New Jersey | 08901 | United States | Details |
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health | RECRUITING | New York | New York | 10016 | United States | Details |
Oregon Health and Science University | RECRUITING | Portland | Oregon | 97239 | United States | Details |
Hospital of the University of Pennsylvania | RECRUITING | Philadelphia | Pennsylvania | 19104 | United States | Details |
NEXT Oncology | RECRUITING | Austin | Texas | 78758 | United States | Details |
The University of Texas MD Anderson Cancer Center | RECRUITING | Houston | Texas | 77030 | United States | Details |
NEXT Oncology | RECRUITING | San Antonio | Texas | 78229 | United States | Details |
University of Wisconsin Clinical Science Center | RECRUITING | Madison | Wisconsin | 53792 | United States | Details |